Responsible pricing in value-based assessment of cancer drugs: real-world data are an inevitable addition to select meaningful new cancer treatments.
about
Responsible pricing in value-based assessment of cancer drugs: real-world data are an inevitable addition to select meaningful new cancer treatments.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Responsible pricing in value-b ...... ningful new cancer treatments.
@en
Responsible pricing in value-b ...... ningful new cancer treatments.
@nl
type
label
Responsible pricing in value-b ...... ningful new cancer treatments.
@en
Responsible pricing in value-b ...... ningful new cancer treatments.
@nl
prefLabel
Responsible pricing in value-b ...... ningful new cancer treatments.
@en
Responsible pricing in value-b ...... ningful new cancer treatments.
@nl
P2860
P1476
Responsible pricing in value-b ...... aningful new cancer treatments
@en
P2093
Wim van Harten
P2860
P356
10.3332/ECANCER.2017.ED71
P577
2017-09-11T00:00:00Z